Month: January 2026

The Supervisory Board of AS Harju Elekter Group decided to increase the share capital of the company by 34,020 euros by issuing new ordinary shares. The increase in the share capital is due to the need to issue new shares to the management board members and key personnel of Harju Elekter and its subsidiaries participating in the option program approved with the resolution of the general meeting on 29 April 2021. A total of 5 members of the Management Board of Harju Elekter Group participated in the share issue related to the implementation of the option program, who subscribed for a total of 54,000 shares for a total of 243,00 euros.   Decisions of the Supervisory Board of AS Harju Elekter Group:Harju Elekter’s share capital will be increased by a maximum of 34,020 euros, i.e., from 11,671,235.10 euros to 11,705,255.10 euros. The...

The Board of Directors of Nilfisk today published its statement, recommending the voluntary all-cash takeover offer from Freudenberg for all shares in Nilfisk and unanimously recommends that shareholders accept the offer. The Board’s recommendation is based on the attractive offer price, transaction certainty, and the strategic rationale of the proposed transaction. The offer price of DKK 140 in cash per share represents an attractive premium compared to historical share prices and values Nilfisk’s share capital at approximately DKK 3.8 billion. The Board also notes that the offer is fully financed and supported by irrevocable undertakings from shareholders representing 50.9% of Nilfisk’s shares, significantly increasing the likelihood of completion. Peter Nilsson, Chair of the Board of Directors of Nilfisk, says:“Following a comprehensive...

Telia Lietuva, AB (hereinafter “Telia Lietuva” or “the Company”) is starting a reorganisation of its Digital & Technology unit as part of a broader digital shift across the Telia Company Group. By deploying digital and artificial intelligence (AI) solutions, the Company plans to reduce its workforce by 59 positions. Telia currently employs around 2,500 people in Lithuania. “Over the past five years, we have consistently digitalised our processes and integrated AI solutions. This has enabled more efficient ways of working and has led us to review the structure of the combined Technology and Digital Transformation unit,” says Vygintas Domarkas, Head of Digital & Technology at Telia Lietuva. The reduction in workforce is not related to individual employee performance or competencies. The decisions are driven by changes of the unit’s...

Today, 07th of January 2026, TKM Auto OÜ, a 100% subsidiary of TKM Grupp AS, signed an agreement to acquire a 100% shareholding in three companies:Rohe Auto AS, with a registered share capital of EUR 120,000, divided into 200,000 shares with a nominal value of EUR 0.60 per share; SKO Motors OÜ, with a registered share capital of EUR 251,000, divided into one share with a nominal value of EUR 251,000; and a real estate holding company to be established prior to completion of the transaction, with a registered share capital of EUR 10,000, divided into one share with a nominal value of EUR 10,000.The main business activities of Rohe Auto AS and SKO Motors OÜ include the sale of vehicles under the Škoda brand, retail and wholesale of spare parts and accessories, and provision of maintenance and repair services in Tallinn and Harju County....

All Fiscal 2026 financial objectives confirmed Q1 Fiscal 2026 Revenues Issy-les-Moulineaux, France – January 7th, 2026 Robust start in the 1st quarter delivering on expectationsAll Fiscal 2026 financial objectives confirmed HighlightsSustained Employee Benefits business performance in Q1 Fiscal 2026 driven by strong new client acquisition and healthy net retention Total Revenues up +9.0% organically, reaching €308m Operating revenue up +9.1% organically to €268m, supported by a strong trajectory in Employee Benefits delivering +11.6% organic growth Float revenue standing at €40m, up +8.5% organically Continued execution of the M&A roadmap with the closing of Skipr in Belgium and France, and ProEves in India, alongside a solid and diversified pipeline Pluxee confirms all its financial objectives for Fiscal 20261 amid an evolving...

Vivoryon Therapeutics N.V. to Attend and Present in Upcoming Conferences Halle (Saale) / Munich, Germany, January 7, 2026 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company developing small molecule medicines for inflammatory and fibrotic disorders, with a primary focus on kidney diseases, today announced that the Company’s management will participate in the following medical and investor conferences: 1x1s around J.P. Morgan Healthcare Conference San Francisco, USADate: January 12-14, 2026To meet the team contact: IR@vivoryon.com UBS European Healthcare Conference London, UKDate: March 3-4, 2026 World Congress of Nephrology (WCN)Yokohama, JapanDate: March 28-31, 2026Link to conference: https://www.theisn.org/wcn/ ### About Vivoryon Therapeutics N.V.Vivoryon is a clinical stage...

Ad Hoc Announcement Pursuant to Art. 53 LR  Geneva, Switzerland, January 7, 2026 – Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that its spin-out company, Neurosterix, has started a Phase 1 clinical study of NTX-253. NTX-253 is a potent, selective, orally available positive allosteric modulator (PAM) of the muscarinic M4 receptor being developed for the treatment of schizophrenia. The Phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of NTX-253 in healthy volunteers. “The progression of NTX-253 into clinical studies represents an important milestone for both Neurosterix and Addex,” said Tim Dyer, Chief Executive...